Liver Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged between 18 and 75 years old
• People who have been diagnosed with recurring liver cancer (cancer that has come back after previous treatment), confirmed by imaging scans
• People whose recurring liver cancer is at an intermediate stage, meaning they have either two to three tumours where at least one is larger than 3 cm, or more than three tumours
• People who have no more than six tumours in total, and where the largest tumour is no bigger than 5 cm
• People whose cancer has not spread outside the liver and has not grown into major blood vessels
• People whose liver function falls within a certain acceptable range, known as Child-Pugh class A or B (confirm with trial site)
• People who received a procedure called TACE (a treatment that delivers therapy directly to liver tumours through the blood vessels) as their first treatment after the cancer came back, and whose cancer did not get worse after that treatment
• People who are expected to live for more than 3 months

Who may not be able to join:

• People who are under 18 or over 75 years of age
• People whose liver cancer has never been treated before (first-time, not recurring)
• People whose recurring liver cancer involves more than six tumours, or who have only a single recurring tumour
• People whose recurring liver cancer tumour is larger than 5 cm
• People whose cancer has spread to other parts of the body outside the liver
• People whose cancer has grown into a major blood vessel in the liver

Important: Always verify eligibility with the trial site directly before applying.